Background:
Hidradenitis suppurativa (HS) is a chronic inflammatory disease characterized by painful inflamed nodules, abscesses, and pus-draining tunnels appearing in axillary, inguinal, and perianal skin areas. HS lesions contain various types of immigrated immune cells.
Objective:
This study aimed to characterize mediators that support lesional B/plasma cell persistence in HS.
Methods:
Skin samples from several cohorts of HS patients and control cohorts were assessed by mRNA sequencing, quantitative PCR on reverse-transcribed RNA, flow cytometry, and immunohistofluorescence. Blood plasma and cultured skin biopsy samples, keratinocytes, dermal fibroblasts, neutrophilic granulocytes (neutrophils), monocytes, and B cells were analyzed. Complex systems biology approaches were used to evaluate bulk and single-cell RNA sequencing data.
Results:
Proportions of B/plasma cells, neutrophils, CD8 T cells, and M and M macrophages were elevated in HS lesions compared to skin of healthy and perilesional intertriginous areas. There was an association between B/plasma cells, neutrophils, and B-cell activating factor (BAFF, aka TNFSF13B). BAFF was abundant in HS lesions, particularly in nodules and abscesses. Among the cell types present in HS lesions, myeloid cells were the main BAFF producers. Mechanistically, granulocyte colony-stimulating factor in the presence of bacterial products was the major stimulus for neutrophils' BAFF secretion. Lesional upregulation of BAFF receptors was attributed to B cells (TNFRSF13C/BAFFR and TNFRSF13B/TACI) and plasma cells (TNFRSF17/BCMA). Characterization of the lesional BAFF pathway revealed molecules involved in migration/adhesion (eg, CXCR4, CD37, CD53, SELL), proliferation/survival (eg, BST2), activation (eg, KLF2, PRKCB), and reactive oxygen species production (eg, NCF1, CYBC1) of B/plasma cells.
Conclusion:
Neutrophil-derived BAFF supports B/plasma cell persistence and function in HS lesions.
Citing Articles
Skin Deep and Beyond: Unravelling B Cell Extracellular Matrix Interactions in Cutaneous Immunity and Disease.
Diehl R, Hubner S, Lehr S, Rizzi M, Eyerich K, Nystrom A
Exp Dermatol. 2025; 34(3):e70068.
PMID: 40051023
PMC: 11885703.
DOI: 10.1111/exd.70068.
Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity.
Vecin N, Balukoff N, Yaghi M, Gonzalez T, Sawaya A, Strbo N
JID Innov. 2025; 5(3):100350.
PMID: 40034103
PMC: 11872476.
DOI: 10.1016/j.xjidi.2025.100350.
Transcriptome and chromatin accessibility landscape of ovarian development at different egg-laying stages in taihe black-bone silky fowls.
Zhang J, Cui Y, Ruan J, Zhu H, Liang H, Cao J
Poult Sci. 2025; 104(3):104864.
PMID: 39922133
PMC: 11851220.
DOI: 10.1016/j.psj.2025.104864.
B cells in non-lymphoid tissues.
Samiea A, Celis G, Yadav R, Rodda L, Moreau J
Nat Rev Immunol. 2025; .
PMID: 39910240
DOI: 10.1038/s41577-025-01137-6.
DNA methylation patterns of circadian and ultradian genes are altered in the peripheral blood of patients with hidradenitis suppurativa.
Radhakrishna U, Ratnamala U, Jhala D, Uppala L, Vedangi A, Saiyed N
Front Immunol. 2024; 15:1475424.
PMID: 39669567
PMC: 11635105.
DOI: 10.3389/fimmu.2024.1475424.
Hidradenitis suppurativa: key insights into treatment success and failure.
van Straalen K, Piguet V, Gudjonsson J
J Clin Invest. 2024; 134(21).
PMID: 39484718
PMC: 11527436.
DOI: 10.1172/JCI186744.
Cellular indexing of transcriptomes and epitopes (CITE-Seq) in hidradenitis suppurativa identifies dysregulated cell types in peripheral blood and facilitates diagnosis via machine learning.
Kumar S, Orcales F, Shih B, Fang X, Yin C, Yates A
Res Sq. 2024; .
PMID: 39315268
PMC: 11419166.
DOI: 10.21203/rs.3.rs-4791069/v1.
The effects of exercise on microRNA expression profiling in adipose tissue macrophages of mice.
Qin F, Huang W, Qu C, Zhao L, Du Y, Zhao T
Front Immunol. 2024; 15:1412621.
PMID: 39224599
PMC: 11366585.
DOI: 10.3389/fimmu.2024.1412621.
Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.
Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z
Signal Transduct Target Ther. 2024; 9(1):225.
PMID: 39198425
PMC: 11358547.
DOI: 10.1038/s41392-024-01947-5.
Patient-reported assessment of medical care for chronic inflammatory skin diseases: an enterprise-based survey.
Wolk K, Schielein M, Maul J, Widmayer F, Wanke K, Fischmann W
Front Med (Lausanne). 2024; 11:1384055.
PMID: 38698787
PMC: 11064793.
DOI: 10.3389/fmed.2024.1384055.
Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development.
Barron A, Fabre T, De S
F1000Res. 2024; 13:54.
PMID: 38681509
PMC: 11053351.
DOI: 10.12688/f1000research.143472.1.
An Atlas of the Hidradenitis Suppurativa Transcriptome.
Szukala W, Lichawska-Cieslar A, Krajewski P, Kulecka M, Rumienczyk I, Mikula M
Dermatol Ther (Heidelb). 2024; 14(2):409-420.
PMID: 38183615
PMC: 10890996.
DOI: 10.1007/s13555-023-01083-y.
Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa.
Lowe M, Cohen J, Moss M, Clancy S, Adler J, Yates A
JCI Insight. 2023; 9(3).
PMID: 38113104
PMC: 10967391.
DOI: 10.1172/jci.insight.169870.
Molecular and functional changes in neutrophilic granulocytes induced by nicotine: a systematic review and critical evaluation.
Brembach T, Sabat R, Witte K, Schwerdtle T, Wolk K
Front Immunol. 2023; 14:1281685.
PMID: 38077313
PMC: 10702484.
DOI: 10.3389/fimmu.2023.1281685.
Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.
Satoh T
J Dermatol. 2023; 51(2):160-171.
PMID: 38031879
PMC: 11484153.
DOI: 10.1111/1346-8138.17028.
Targeting Metabolic Syndrome in Hidradenitis Suppurativa by Phytochemicals as a Potential Complementary Therapeutic Strategy.
Witte K, Wolk K, Witte-Handel E, Krause T, Kokolakis G, Sabat R
Nutrients. 2023; 15(17).
PMID: 37686829
PMC: 10490062.
DOI: 10.3390/nu15173797.
Blood T Helper Memory Cells: A Tool for Studying Skin Inflammation in HS?.
Witte K, Schneider-Burrus S, Salinas G, Mossner R, Ghoreschi K, Wolk K
Int J Mol Sci. 2023; 24(10).
PMID: 37240200
PMC: 10219182.
DOI: 10.3390/ijms24108854.